Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Vanda Pharmaceuticals Inc

+ Add to Watchlist

VNDA:US

9.3400 USD 0.0800 0.86%

As of 20:10:00 ET on 03/30/2015.

Snapshot for Vanda Pharmaceuticals Inc (VNDA)

Open: 9.4000 Day's Range: 9.1500 - 9.4000 Volume: 466,123
Previous Close: 9.2600 52wk Range: 8.3350 - 17.6900 1-Yr Rtn: -42.52%

Stock Chart for VNDA

No chart data available.
  • VNDA:US 9.3400
  • 1D
  • 1M
  • 1Y
9.2600
Interactive VNDA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VNDA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9798
Est. EPS (USD) (12/2015) -1.6050
Est. PEG Ratio -
Market Cap (M USD) 388.93
Shares Outstanding (M) 41.64
30 Day Average Volume 1,005,692
Price/Book (mrq) 2.4095
Price/Sale (ttm) 6.5002
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VNDA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VNDA

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.

Mihael H PolymeropoulosPresident/CEO/Co-FounderJames Patrick Kelly "Jim"Senior VP/CFO/Treasurer/Secy
Paolo BaroldiSenior VP/Chief Medical Officer
More Company Profile & Key Executives for VNDA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil